
Daily insulin injections make it hard
for many diabetics to control blood sugar well enough to prevent serious complications like blindness and kidney failure. Now Pfizer and Sanofi-Aventis offer up the painless Exubera, an inhaler that delivers aerosolized insulin to the lungs, which quickly absorb the drug over their large surface area. A single puff just before meals can stabilize blood sugar as effectively as a shot. A Food and Drug Administration panel voted to approve Exubera this fall based on results from more than 52 clinical trials conducted over 10 years.

Every year, PopSci honors the top 100 innovations in categories such as consumer products, medical tech and engineering.
Learn more and submit your product or technology today at popsci.com/enter.
Share your photos in the Pop Sci pool at www.flickr.com!
Will the FDA clear deep-brain stimulation as a treatment for clinical depression by September 30, 2008?
Will the LHC be fully functional and producing data by October 31, 2008?

